V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215384 | 20155553 | 1.8 | 114.4 | Palliative (P) | 2019-05-26 | 2019-08-31 | EOX | 02 | N | EOX | 100170904 |
| 20215385 | 20155554 | 1.91 | 75.9 | Palliative (P) | 2019-08-22 | 2019-09-04 | Trial Unspecified | 02 | N | TRIAL | 100386693 |
| 20215389 | 20155555 | 1.82 | 76 | Neo-adjuvant (N) | 2019-02-06 | 2019-02-14 | null | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101009639 |
| 20215390 | 20155556 | 1.76 | 62.8 | null | 2018-12-15 | 2018-12-29 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100711634 |
| 20215397 | 20155557 | 1.71 | 73.1 | Palliative (P) | 2020-02-20 | 2020-02-28 | EOX | N | null | CETUXIMAB + IRINOTECAN + MDG | 100150669 |
| 20215400 | 20155558 | 1.63 | null | Palliative (P) | 2018-06-29 | 2018-06-29 | Sorafenib | 02 | N | SORAFENIB | 101715243 |
| 20215403 | 20155559 | 1.62 | 67 | Curative (C) | 2017-05-21 | 2017-05-21 | Capecitabine 35days + RT | N | Y | EOX | 100550894 |
| 20215404 | 20155560 | 1.74 | 0 | Palliative (P) | 2020-05-14 | 2020-05-28 | CETUXIMAB + IRINOTECAN + MDG | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 101527618 |
| 20215413 | 20155561 | 1.76 | 60.5 | Curative (C) | 2017-01-12 | 2017-02-20 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100988285 |
| 20215415 | 20155562 | 1.79 | 48.6 | null | null | null | EOX | 02 | N | SORAFENIB | 100805659 |
| 20215417 | 20155563 | 1.88 | 62.7 | Palliative (P) | 2018-12-17 | 2019-04-14 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101228387 |
| 20215419 | 20155564 | 1.8 | null | Neo-adjuvant (N) | 2020-07-15 | 2020-09-03 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101006178 |
| 20215420 | 20155565 | 1.8 | 120.5 | Palliative (P) | 2016-06-29 | 2016-07-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101365679 |
| 20215421 | 20155566 | 1.76 | 67.5 | Adjuvant (A) | 2018-04-22 | 2018-09-15 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100835833 |
| 20215422 | 20155567 | 1.8 | 68.2 | null | 2018-03-01 | 2018-09-21 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100248825 |
| 20215424 | 20155568 | 1.69 | 54.55 | null | 2019-03-17 | 2019-03-19 | EOX | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 100294122 |
| 20215429 | 20155569 | 1.87 | 66.4 | Palliative (P) | null | null | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100115985 |
| 20215430 | 20155570 | 1.55 | 54.8 | null | 2017-05-31 | 2017-06-03 | EOX | N | null | CETUXIMAB + IRINOTECAN + MDG | 101228771 |
| 20215431 | 20155571 | 1.66 | 50.3 | null | 2018-10-17 | 2019-02-06 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101336993 |
| 20215433 | 20155572 | 1.78 | null | null | 2019-05-13 | 2019-09-04 | EOX | 02 | null | SORAFENIB | 100254615 |
| 20215437 | 20155573 | 1.82 | 72 | null | 2017-01-01 | 2017-01-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100782167 |
| 20215438 | 20155574 | 1.66 | null | Adjuvant (A) | 2019-08-28 | 2019-11-06 | Sorafenib | 02 | N | SORAFENIB | 101292259 |
| 20215442 | 20155575 | 1.81 | 76.5 | Adjuvant (A) | 2021-07-11 | 2021-07-24 | EOX | 02 | N | EOX | 101053406 |
| 20215444 | 20155576 | 1.64 | 74 | Palliative (P) | 2019-03-29 | 2019-06-14 | EOX | 2 | N | EOX | 101141866 |
| 20215445 | 20155577 | 1.49 | 66.1 | Palliative (P) | 2019-07-08 | 2019-07-24 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101363802 |
| 20215448 | 20155578 | 1.69 | 48 | Adjuvant (A) | 2017-10-15 | 2018-03-30 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 100187902 |
| 20215449 | 20155579 | 0 | 80.3 | Neo-adjuvant (N) | 2019-10-12 | 2019-10-19 | Cetuximab + Oxaliplatin + MdG Maint | N | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101045602 |
| 20215456 | 20155580 | 0 | 71.9 | Palliative (P) | 2017-06-25 | 2017-10-18 | Cetuximab + FOLFIRI cycle1 | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101563720 |
| 20215466 | 20155581 | 1.72 | 74.7 | Palliative (P) | 2018-06-07 | 2018-06-21 | CETUXIMAB + IRINOTECAN + MDG | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 101865156 |
| 20215467 | 20155582 | 1.58 | 62.8 | Palliative (P) | 2019-07-24 | 2020-03-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101059272 |
| 20215475 | 20155583 | 1.84 | 80 | Palliative (P) | 2019-09-03 | 2019-09-10 | Trial Unspecified | Y | N | TRIAL | 101253268 |
| 20215477 | 20155584 | 1.75 | 70 | Palliative (P) | 2018-07-06 | 2018-08-29 | Sorafenib | 02 | null | SORAFENIB | 101631356 |
| 20215483 | 20155585 | 1.72 | 57.3 | Palliative (P) | 2019-03-05 | 2019-03-07 | EOX | 02 | Y | EOX | 101002288 |
| 20215484 | 20155586 | 1.63 | 46.8 | Palliative (P) | 2017-06-09 | 2018-01-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100994397 |
| 20215488 | 20155587 | 1.72 | 76.4 | null | 2017-01-20 | 2017-02-18 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100712956 |
| 20215490 | 20155588 | 1.89 | 108 | null | 2017-08-28 | 2017-09-16 | IRINOTECAN + MDG + PANITUMUMAB | 01 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101320273 |
| 20215493 | 20155589 | 1.62 | 60.4 | Palliative (P) | 2018-05-25 | 2018-06-11 | CAPECITABINE + RT | 99 | N | CAPECITABINE + RT | 101329471 |
| 20215499 | 20155590 | 1.51 | 40.4 | Curative (C) | 2022-01-05 | 2022-01-12 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100580590 |
| 20215505 | 20155591 | 1.74 | 94 | Neo-adjuvant (N) | 2017-02-06 | 2017-02-21 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101360998 |
| 20215507 | 20155592 | 1.69 | 92 | Palliative (P) | null | 2018-01-24 | EOX | 2 | N | EOX | 101337926 |
| 20215513 | 20155593 | 1.83 | 92.8 | Palliative (P) | 2020-06-02 | 2020-06-05 | Sorafenib | 02 | N | SORAFENIB | 101683326 |
| 20215523 | 20155594 | 1.91 | 85 | Neo-adjuvant (N) | 2017-06-10 | 2017-06-22 | Sorafenib | 02 | N | SORAFENIB | 101113970 |
| 20215525 | 20155595 | 1.85 | 117 | Neo-adjuvant (N) | 2021-01-16 | 2021-01-24 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101541250 |
| 20215527 | 20155596 | 1.91 | 71.4 | Palliative (P) | 2016-05-24 | 2016-08-07 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101021453 |
| 20215528 | 20155597 | 1.93 | 95 | Palliative (P) | 2020-01-30 | 2020-11-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101016726 |
| 20215533 | 20155598 | 1.43 | 111.3 | Adjuvant (A) | 2017-08-11 | 2017-08-12 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100072129 |
| 20215534 | 20155599 | 0 | 54.3 | Neo-adjuvant (N) | 2019-09-27 | 2019-10-16 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100896720 |
| 20215538 | 20155600 | 1.6 | 67.5 | Neo-adjuvant (N) | 2022-04-17 | 2022-04-30 | EOX | 02 | N | EOX | 100290366 |
| 20215539 | 20155601 | 0 | 79 | Palliative (P) | 2019-03-14 | 2019-03-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101700433 |
| 20215540 | 20155602 | 1.78 | 61.4 | Palliative (P) | 2018-02-15 | 2018-03-07 | FLUOROURACIL + IRINOTECAN + Panitumumab | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101205920 |